|
|
Expression information for OLFML3 (Homo sapiens) (Information derived after consensus based scoring of curated data)
|
Tissue/Sub tissue | Condition/Sub Condition | Expression status | Reliability score | References |
Endometrium | Endometrial cancer | Transcribed | 158 | | Uterus | Leiomyoma | Transcribed | 68 | | Uterus | Normal | Transcribed | 30 | | Endometrium | Normal | Transcribed | 14 | | Myometrium | Normal | Transcribed | 12 | | Endometrium | Endometriosis | Transcribed | 2 | | Uterus | Leiomyosarcoma | Not Available | Not Available | | Cervix | Normal | Dormant | 2 | | Uterus | CIN/Cervical dysplasia | Dormant | 8 | | Cervix | Cervical cancer | Dormant | 74 | | |
NGS based expression information for OLFML3 (Homo sapiens) (Information from literature curation)
|
Study | Condition | Expression status |
Llorens et al. Multiple platform assessment of the EGF dependent transcriptome by microarray and deep tag sequencing analysis. BMC Genomics 2011 Jun 23;12:326. | EGF treated vs. untreated control HeLa cells | Up-regulated |
Lebedeva et al. Transcriptome-wide analysis of regulatory interactions of the RNA-binding protein HuR. Mol Cell 2011 Aug 5;43(3):340-52. | ELAVL1/HuR knock down vs. mock knockdown HeLa cells | Not available |
Yang et al. Genomewide characterization of non-polyadenylated RNAs. Genome Biol. 2011;12(2):R16. | Poly A(-) vs. ploy A(+) RNA fraction of HeLa cells | Not available |
|
EST based expression for OLFML3 (Homo sapiens) (Information obtained from UniGene database)
|
UniGene cluster ID |
Tissue/Condition |
EST count |
Transcripts per million |
Hs.9315 | Uterus | 66 | 283 | Hs.9315 | Cervix | 22 | 456 | Hs.9315 | Uterine tumor | 5 | 55 | Hs.9315 | Cervical tumor | 7 | 203 | |